Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: A Journey To Focus On Data And Digital

April 09, 2018 | Novartis announced it would buy gene therapy pioneer AveXis for $8.7 billion, giving the Swiss drug giant several treatments for rare diseases that work by inserting new DNA into patients' cells. Forbes